1.Studies on antioxidation of extract from Ruppia rostellata koch
Jiamin ZHANG ; Xin QIU ; Pingyuan HUANG ; Weichao TANG
Chinese Journal of Marine Drugs 1994;0(02):-
Extract from Ruppia rostellata Koch was divided into three parts: petroleum ether part, CH2Cl2 and water-soluble part. Each part of them was studied upon it's antioxidation. The results indicated that the active compounds were only in the water-soluble part. In soybean oil, the antioxidation of water-soluble part was stronger than that of BHA and V. E. , In lard, the antioxidation of water-solubile part was a little weaker than that of BHA and V.E.
2.Craniotomy in traumatic frontal sinus fracture cerebrospinal fluid leaks
Yongjia DENG ; Chengyi LUO ; Jianping LIU ; Ting LIU ; Weichao HUANG
Chinese Journal of Primary Medicine and Pharmacy 2016;23(6):904-907
Objective To assess the craniotomy in traumatic frontal sinus fracture cerebrospinal fluid( CSF) leaks.Methods Clinical data of 12 traumatic frontal sinus fracture CSF leaks from January 2010 to December 2014, who treated by craniotomy and conservation treatment was invalid were reviewed.Combined typical clinical presenta-tion and basicranial thin-layer computed tomography(CT),made qualitative diagnosis and localization.Craniotomy by bilateral coronary incision and epidural approach was performed.Repairation was mainly for the endocranium and the basicranium.Bone cement was used to reconstruct the osseous defect of the frontal sinus,and then with pedicle periosteal flap coverage.Dural defects was fixed with autogenous fascia.After operation,staying in bed and using anti-biotic for 7-14 days were required,while mannital or lumbar-drainage as needed.Results All 12 cases got posi-tive preoperative CT results.Craniotomy was performed,succeeded without reoperation.None of intracranial infection happened,while 1 case suffered from anosphrasia.Followed up for 3 -12 months, none CSF leaks relapsed. Conclusion Craniotomy by coronary incision,dispose the endocranium and the basicranium for the patients who suf-fered from frontal sinus fracture CSF leaks while conservation treatment is invalid,can obtain satisfied result.
3.Verification of the linear range and the minimum detection limit in real-time fluorescence quantitative PCR for HBV DNA
Yunhong ZHANG ; Weichao QIN ; Ling HE ; Jianjun HUANG
International Journal of Laboratory Medicine 2014;(17):2362-2363,2366
Objective Use real-time fluorescence quantitative polymerase chain reaction(PCR)to determine HBV DNA,then calculate the linear range and the minimum detection limit,which are the main performance indicators in the laboratory verification. Methods According to the related documents,by serial dilution of high concentration samples,samples of serial concentrations were obtained which were out of the linear range mentioned in the instructions,then verifid the new linear range.By serial dilution of low concentration,samples were obtained,the concentrations of which were lower than the minimum detection limit of provide by the manufacturer,then the new minimum detection limit was verified.Results The linear range of HBV DNA detection was 8.58× 102 -8.41×107 IU/mL,and the minimum detection limit of HBV DNA detection was 4.07 ×102 IU/mL.Conclusion The linear range and the minimum detection limit of Real-time fluorescence quantitative PCR assessed reaches the expected requirement,and the method and validation scheme are simple and feasible.
4.The Effect of Tongfu Huayu Daotan Decoction on Concentrations of Serum S-100β, NSE and Prognosis in Patients with Severe Craniocerebrai Injury
Jianlong HUANG ; Yunhui LI ; Zhongpin LIN ; Weichao WU ; Haibiao LAI ; Weiqiang WU ; Xiangming GU ; Weiye LAI
International Journal of Traditional Chinese Medicine 2008;30(5):326-327
Objective To explore the effects of Tongfu Huayu Daotan Decoction (通化阏导痰汤)on the serum concentration of S-100β protein, neuron-specific enolase(NSE) and Prognosis in patients with severe craniocerebral injury.Methods Sixty patients with severe craniocerebral injury were randomly divided into a a'eatment group and a control group.The treated group was treated with Tongfu Huayu Daotan Decoction plus conventional treatments including dehydration,antibiotics, organ functional support, nerve nutrition, prevention of complication, etc.; the control group was treated with conventional treatments alone. The concentration of serum S-100β protein and neuron-specific enolase(NSE) in plasma at admission and at24, 36, 72huors, and 5, 7 days after treatment were determined respectively; the Glasgow outcome scale (GOS)and neurological deficits scoring at 2weeks and 4weeks after hospitalization were compared to observe the efficacy of the patients. Results The concentration of serum S-100β protein and neuron-specific enolase (NSE) in plasma at previous treatment and at 24, 36 hours after the treatment had no statistical difference in the two groups(P>0.05 ), The concentration of serum S-100β protein and neuron-specific enolase (NSE) in plasma at 72huors, 5 and 7 days after the treatment in the Tongfu Huayu Daotan Decoction group were lower than those in the control group, the differences being significant (P<0.01). The Glasgow outcome scale (GOS) and neurological deficits scoring at 2weeks and 4weeks after the treatment in the Tongfu Huayu Daotan Decoction group were significantly nigher than those in the control group, the differences being significant (P<0.01) .Conclusion Tongfu Huayu Daotan Decoction can alleviate the plasma concentrations of S-100β protein and neuron-specific enolase (NSE) in patients with severe craniocerebral injury and markedly improve the clinical therapeutic effects. Combined Tongfu Huayu Daotan Decoction and western medicine can significantly reduce mortality and improve the Glasgow outcome scale (GOS), neurological deficits scoring and therapeutic effect.
5.Analysis of clinical characteristics of 22 906 gravidas with Hepatitis B Virus infection
Feifeng LI ; Guosheng YUAN ; Yuanping ZHOU ; Hongbo ZHOU ; Weichao TAN ; Nianhuan YANG ; Junwei LIU ; Huaping HUANG ; Yunfei GAO
The Journal of Practical Medicine 2016;32(8):1335-1338
Objective To analyze the clinical characteristics of gravidas with HBV in Nanfang Hospital from 2008 to 2014. Methods 22 906 gravidas were retrospectively investigated. Results The HBsAg positive rates were 11.64% and 6.16% when the gravidas were divided into Cantonese and non-Cantonese groups (χ2 =193.370, P < 0.005). The ALT abnormal rates in HBeAg positive and HBeAg negative gravidas were 17.96% and 6.68% (χ2=62.594, P<0.005). Conclusion The HBsAg positive rate of gravidas in Guangdong and the ALT abnormal rate of HBeAg positive gravidas are higher.
6.Investigation of ABO allelic competition phenomena in a pedigree with Bw11 subtype.
Chenchen FENG ; Weichao REN ; Daosheng CHENG ; Jingyan GAO ; Jianyong CHEN ; Weichao LI ; Jianyu XIAO ; Taixiang LIU ; Chengyin HUANG ; Qing CHEN
Chinese Journal of Medical Genetics 2021;38(1):23-26
OBJECTIVE:
To investigate the serological and molecular characteristics of a pedigree carrying an allele for ABO*BW.11 blood subgroup.
METHODS:
The ABO blood type of 9 pedigree members were determined by serological methods. Exons 6 and 7 of the ABO gene were amplified by PCR and directly sequenced. The patient and her father were also subjected to clone sequencing analysis.
RESULTS:
Serological tests demonstrated that the proband and her younger brother had an ABw subtype, whilst her father and two daughters had Bw subtype. Clone sequencing found that the exon 7 of the ABO gene of the proband had a T>C substitution at position 695, which was identified as a BW.11 allele compared with the reference sequence B.01. This BW.11 allele was also identified in the proband's father, brother and two daughters. Due to allelic competition, the A/BW.11 and BW.11/O alleles demonstrated significantly different phenotypes.
CONCLUSION
The c.695T>C substitution of the ABO gene may lead to allelic competition in the Bw11 subtype. Combined molecular and serological methods is helpful for precise blood grouping.
ABO Blood-Group System/genetics*
;
Alleles
;
Female
;
Genotype
;
Humans
;
Male
;
Pedigree
;
Phenotype
7. Analysis of the efficacy of relieving the postoperation pain by using mesh to stuture and fixate tissue during transabdominal preperitoneal hernioplasty in inguinal hernia patients
Chong WANG ; Yingchang ZHU ; Weichao LIANG ; Qisheng CHEN ; Xiong LIANG ; Minghui TAN ; Xiaoxiao HUANG
International Journal of Surgery 2019;46(9):631-633
Objective:
To study the efficacy of relieving the postoperation pain by using mesh to stuture and fixate tissue during transabdominal preperitoneal hernioplasty (TAPP) in inguinal hernia patients.
Metholds:
A retrospective analysis of 156 patients with inguinal hernia who underwent TAPP in Nanhai Hospital Affiliated to Southern Medical University from January 2016 to January 2017 was conducted, they were males, the average age was 50.84 years and the age range was from 33 to 62 years. Patients were divided into sacral nail group (
8.Half effective dose of propofol sedation inhibiting response to inserted gastroscope with Dixon sequential method in eldly patients
Yangxinrui HUANG ; Hong TAN ; Weichao LIU ; Fukun LIU
International Journal of Surgery 2023;50(10):692-697
Objective:To study the half effective dose of propofol inhibiting pharyngeal response of elderly patients to inserted gastroscope under anesthesia by Dixon sequential method.Methods:In this prospective study, 31 elderly patients aged 75 to 84 years who planned to undergo painless gastroscopy at the Digestive Endoscopy Center of Beijing Friendship Hospital, Capital Medical University from March to June 2021 were enrolled, American Society of Anesthesiologists class Ⅰ-Ⅱ. The heart rate (HR), mean arterial pressure (MAP), peripheral pulse oxygen saturation (SpO 2) were monitored. The propofol dose started at 1.1 mg/kg (the first patient), and the gap dose was 0.1 mg/kg. The sequential dose given to the patient increased by 0.1 mg/kg if the pharyngeal response to inserted gastroscope of the previous patient was not considered inhibited or decreased by 0.1 mg/kg if the pharyngeal response was inhibited, the positive pharyngeal response-inhibited pharyngeal response was regarded as one crossover, and this study stopped after the seventh crossover. The change of MAP, HR and SpO 2 prior to anesthesia, insertion of gastroscope, 2 minutes after insertion, after gastroscopy was recorded. Nausea and vomiting, cough and swallowing, and body movement were also recorded. The measurement data were expressed as mean ± standard deviation ( ± s), and the changes at different time points were compared by repeated measurement data ANOVA. Results:The half effective dose of propofol inhibiting pharyngeal response to inserted gastroscope was (1.11±0.16) mg/kg. The MAP prior to anesthesia, insertion of gastroscope, 2 minutes after insertion, after gastroscopy were (105.05±13.39) mmHg, (90.48±10.98) mmHg, (90.48±11.11) mmHg, (82.68±9.98) mmHg, respectively, and the MAP at each observation point after administration was significantly lower than that before anesthesia, the differences were statistically significant ( P<0.05). The HR prior to anesthesia, insertion of gastroscope, 2 minutes after insertion, after gastroscopy were 77.26±12.67, 72.81±10.39, 72.90±11.63, 68.32±9.42, respectively, and the HR at each observation point after administration was significantly lower than that before sedation, the differences were statistically significant ( P<0.05). The SpO 2 prior to anesthesia, insertion of gastroscope, 2 minutes after insertion, after gastroscopy were (96.48±1.81)%, (98.65±1.31)%, (97.36±2.14)%, (96.48±1.81)%, respectively, and the SpO 2 prior to anesthesia was statistically significant compared with insertion of gastroscope ( P<0.001), the SpO 2 of 2 minutes after insertion, and after gastroscopy were significant differences compared with insertion of gastroscope ( P<0.05). Conclusion:Half effective dose of propofol for inhibiting pharyngeal response to inserted gastroscope under anesthesia by Dixon sequential method was determined as (1.11±0.16)mg/kg .
9.A Risk Prediction Model for Invasive Fungal Disease in Critically Ill Patients in the Intensive Care Unit.
Fangyi LI ; Minggen ZHOU ; Zijun ZOU ; Weichao LI ; Huang HUANG ; He ZHIJIE
Asian Nursing Research 2018;12(4):299-303
PURPOSE: Developing a risk prediction model for invasive fungal disease based on an analysis of the disease-related risk factors in critically ill patients in the intensive care unit (ICU) to diagnose the invasive fungal disease in the early stages and determine the time of initiating early antifungal treatment. METHODS: Data were collected retrospectively from 141 critically ill adult patients with at least 4 days of general ICU stay at Sun Yat-sen Memorial Hospital, Sun Yat-sen University during the period from February 2015 to February 2016. Logistic regression was used to develop the risk prediction model. Discriminative power was evaluated by the area under the receiver operating characteristics (ROC) curve (AUC). RESULTS: Sequential organ failure assessment (SOFA) score, antibiotic treatment period, and positive culture of Candida albicans other than normally sterile sites are the three predictors of invasive fungal disease in critically ill patients in the ICU. The model performs well with an ROC-AUC of .73. CONCLUSION: The risk prediction model performs well to discriminate between critically ill patients with or without invasive fungal disease. Physicians could use this prediction model for early diagnosis of invasive fungal disease and determination of the time to start early antifungal treatment of critically ill patients in the ICU.
Adult
;
Candida albicans
;
Critical Care*
;
Critical Illness*
;
Early Diagnosis
;
Humans
;
Intensive Care Units*
;
Logistic Models
;
Retrospective Studies
;
Risk Factors
;
ROC Curve
;
Solar System
10.Review of dendritic cell vaccine in the treatment of hepatocellular carcinoma
Weichao DOU ; Peng CHEN ; Ming HUANG ; Feng LIU ; Min HE ; Mingdao HU
Chinese Journal of Hepatobiliary Surgery 2017;23(12):853-857
Hepatocellular carcinoma (HCC) is the most common malignant tumor of liver.HCC is characterized with poor early detection rate and rapid progression.Therefore,bringing the patients with heavy burden of disease,though poor prognosis.Conventional treatment options can include surgical resection or liver transplantation,trans-arterial chemoembolization,ablation,and targeted therapy,but it remains unsatisfying in prognosis improvement.By years,we have come to realize the role of dendritic cells in tumor immunotherapy.Dendritic cells will become a promising treatment option in improvement of prognosis of HCC patients.In this review,we will focus on current trends and updates on dendritic cell vaccines in HCC treatment.